Dehydroepiandrosterone retards atherosclerosis formation through its conversion to estrogen: The possible role of nitric oxide

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 3, 2000, Pages 782-792

  Hayashi, Toshio ^a   Esaki, Teiji ^a   Muto, Emiko ^a   Kano, Hatsuyo ^a   Asai, Yukako ^a   Thakur, Navin Kumar ^a   Sumi, Daigo ^a   Jayachandran, Muthuvel ^a   Iguchi, Akihisa ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Aromatase; Atherosclerosis; Dehydroepiandrosterone; Estrogen; Nitric oxide

Indexed keywords

AROMATASE INHIBITOR; CHOLESTEROL; ESTRADIOL; ESTROGEN; FADROZOLE; NITRIC OXIDE; PRASTERONE SULFATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL INTAKE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HISTOPATHOLOGY; HORMONAL REGULATION; LIPID STORAGE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; OVARIECTOMY; OXIDATION; PRIORITY JOURNAL; RABBIT;

EID: 0034103177     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.3.782     Document Type: Article

References (60)

1. Hobbkirk R. Steroid sulfotransferases and steroid sulfate sulfatases: characteristic and biological roles. Can J Biochem Cell Biol. 1985;63: 1127-1144.
2. Barett-Connor E, Khan KT, Yen SSC. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med. 1986;66:57-61.
3. Arad Y, Badimon JJ, Badimon L, Hembree WC, Ginsberg HN. Dehydroepiandrosterone feeding prevents aortic fatty streak formation and cholesterol accumulation in cholesterol-fed rabbit. Arteriosclerosis. 1989; 9:159-166.
4. Gordon GB, Bush DE, Weisman HF. Reduction of atherosclerosis by administration of dehydroepiandrosterone. J Clin Invest. 1988;82: 712-720.
5. Nestler JE, Barlascini CO, Clore JN, Blackard WG. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab. 1988;66:57-61.
6. Orentreich N, Brind JL, Rizer RL, Vogelman JH. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab. 1984;59:551-555.
7. Rajalakshmi M, Leask JTS, Walles GMH. In vitro metabolism of androgens by mammalian caudal epididymal spermatozoa. Steroids. 1978;331:747-760.
8. Okabe T, Haji M, Takayanagi R, Adachi M, Imasaki K, Kurimoto F, Watanabe T, Nawata H. Up-regulation of high-affinity dehydroepiandrosterone binding by dehydroepiandrosterone in activated human T lymphocytes. J Clin Endocrinol Metab. 1995;80:2993-2996.
9. Stampfer JM, Colditz GA, Willett WC. Postmenopausal estrogen therapy and cardiovascular disease: ten year follow up from the Nurses' Health Study. N Engl J Med. 1991;325:156-762.
10. Nabulsi AA, Folsom AR, White A. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med. 1993;328:1069-1075.
11. Sullivan JM. Estrogen replacement. Circulation. 1996;94:2699-2702.
12. Walsh B, Schiff I, Rosner B, Greenberg L, Ravinkar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoprotein. N Engl J Med. 1991;325: 1196-1204.
13. Karas RH, Baur WE, van Eickles M, Mendelsohn ME. Human vascular smooth muscle cells express an estrogen receptor isoform. FEBS Letters. 1995;377:103-108.
14. Venkov CD, Rankin AB, Vaughan DE. Identification of authentic estrogen receptor in cultured endothelial cells: a potential mechanism for steroid hormone regulation of endothelial function. Circulation. 1996;94: 727-733.
15. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO III. Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women. Am J Cardiol. 1995;75:264-268.
16. Holm P, Andersen HL, Arroe G, Stender S. Gender gap in aortic cholesterol accumulation in cholesterol-clamped rabbits: role of the endothelium and mononuclear-endothelial cell interaction. Circulation. 1998;98: 2731-2737.
17. Ben-Hur H, Mor G, Insler V, Blickstein I, Amir-Zaltsman Y, Sharp A, Globerson A, Kohen F. Menopause is associated with a significant increase in blood monocyte number and a relative decrease in the expression of estrogen receptors in human peripheral monocytes. Am J Reprod Immunol. 1995;34:363-369.
18. Suzuki A, Mizuno K, Ino Y, Okada M, Kikkawa F, Mizutani S, Tomoda Y. Effect of 17β-estradiol and progesterone on growth-factor-induced proliferation and migration in human female aortic smooth muscle cells in vitro. Cardiovasc Res. 1996;32:516-523.
19. Negre-Salvayre A, Pieraggi MT, Mabile L, Salvayre R. Protective effects of 17β-estradiol against the cytotoxicity of minimally oxidized LDL to cultured bovine aortic endothelial cells. Atherosclerosis. 1993;99: 207-217.
20. Keaney JF, Shwaery GT, Nicolosi RJ, Loscalzo J, Foxall T, Vita J. 17β-Estradiol preserves endothelial vasodilator function and limits low density lipoprotein oxidation in hypercholesterolemic swine. Circulation. 1994;89:2251-2259.
21. Adams MR, Kaplan JF, Manuck SR, Koritnik DR, Parks JS, Wolfe MS, Clarkson TB. Inhibition of coronary artery atherosclerosis by 17β-estradiol in ovariectomized monkeys. Arteriosclerosis. 1990;10: 1051-1057.
22. Haarbo J, Leth-Espensen P, Stender S, Christiansen C. Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol-fed rabbits. J Clin Invest. 1991;87:1274-1279.
23. Wagner JD, Clarkson TB, St Clair RW, Schwenke DC, Shively CA, Adams MR. Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J Clin Invest. 1991;88: 1995-2002.
24. Zeiher AM, Drexler H, Saubier B, Just H. Endothelium-mediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest. 1993;92:652-662.
25. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002-2012.
26. Niu XF, Smith CW, Kubes P. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ Res. 1994;74:1133-1140.
27. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr, Shin WS, Liao JK. Nitric oxide decreases cytokine-induced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest. 1995;96:60-68.
28. Hayashi T, Yamada K, Esaki T, Ishikawa T, Hidaka H, Iguchi A. Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem Biophys Res Commun. 1995;214:847-855.
29. Hayashi T, Fukuto JM, Ignarro LJ, Chaudhuri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc Natl Acad Sci U S A. 1992;89: 11259-11263.
30. Hayashi T, Fukuto JM, Ignarro LJ, Chaudhuri G. Gender difference in atherosclerosis: possible role of nitric oxide. J Cardiovasc Pharmacol. 1995;26:792-802.
31. Holm P, Korsgaard N, Shaimi M, Anderson L II, Iiougaard P, Skouby SO, Stender S. Significant reduction of the antiatherogenic effect of estrogen by long-term inhibition of nitric oxide synthesis in cholesterol-clamped rabbits. J Clin Invest. 1997;100:821-828.
32. Richmond W. Use of cholesterol oxidase for assay of total and free cholesterol in serum by continuous-flow analysis. Clin Chem. 1976;22: 1579-1588.
33. Lipid Research Clinics Program Manual of Laboratory Operations: Volume 1, Lipid and Lipoprotein Analysis. 2nd ed. Washington, DC: US Government Printing Office; US Dept of Health, Education, and Welfare publication No. (NIH) 76-628. 1982:51-59.
34. Witztum JL, Simmons D, Steinberg D, Beltz WF. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol and colestipol hydrochloride. Circulation. 1989;79:16-28.
35. Gaskell SJ, Finlay EM, Pike AW. Analyses of steroids in saliva using highly selective mass spectrometric techniques. Biomed Mass Spectrom. 1980;7:500-504.
36. Weiner BH, Ockene IS, Hoogasian JJ. Inhibition of atherosclerosis by cod-liver oil in a hyperlipidemic swine model. N Engl J Med. 1986;315: 841-845.
37. Badimon JJ, Badimon L, Fuster V. Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. J Clin Invest. 1990;85:1223-1241.
38. Malinski T, Taha Z. Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor. Nature. 1992;358:676-678.
39. Ichimori K, Fukahori H, Nakazawa H, Murakami E. Practical nitric oxide measurement employing a nitric oxide-selective electrode. Rev Sci Instrum. 1994;65:1-5.
40. Yamada K, Nabeshima T. Simultaneous measurement of nitrite/nitrate levels as indices of nitric oxide release in the cerebellum of conscious rats. J Neurochem. 1997;68:1234-1243.
41. Hayashi T, Esaki T, Muto E, Kuzuya M, Iguchi A. The β-adrenoreceptor antagonist, nipradilol, preserves the endothelial nitric oxide response in atherosclerotic vessels of rabbit. Life Sci. 1997;61:1379-1387.
42. Chilvers ER, Giembycz MA, Challiss RA, Bames BJ, Nahorski SR. Lack of effect of zaprinast on methacholine-induced contraction and inositol 1,4,5-trisphosphate accumulation in bovine tracheal smooth muscle. Br J Pharmacol 1991;103:1119-1125.
43. Lowry OH, Rosebrough NJ, Fair AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
44. Houjou T, Wada T, Yasutome M. Effect of aromatase inhibitor CGS 16946A on endocrine behavior in female rats, in comparison with ovariectomized rats. Endocr Surg. 1992;9:13-18.
45. Miller AA, Lipton A, Henderson IC, Navari R, Mulagha MT, Cooper J. Fadrozole hydrochioride in postmenopausal patients with metastatic breast carcinoma. Cancer. 1996;78:789-793.
46. Nathan L, Chaudhuri G. Estrogens and atherosclerosis. Annu Rev Pharmacol Toxicol. 1997;37:477-515.
47. Ganong WF. Review of Medical Physiology. 15th ed. East Norwalk, Connecticut: Appleton & Lange; 1991.
48. Larsen BA, Nordestgaard BG, Stender S, Kjeldsen K. Effect of testosterone on atherogenesis in cholesterol-fed rabbits with similar plasma cholesterol levels. Atherosclerosis. 1993;99:79-86.
49. Adams MR, Williams JK, Kaplan JR. Effects of androgens on coronary artery atherosclerosis and atherosclerosis-related impairment of vascular responsiveness. Arterioscler Thromb Vasc Biol. 1995;15: 562-570.
50. Maillard N, Wolczynski S, Argyriou A, Drosdowsky MA, Foucault P, Carreau S. Steroidogenesis in the two enriched-Leydig cell populations of human testis: evidence for a positive control by semiferous tubules secreted factor(s). Arch Androl. 1994;33:187-199.
51. Holm P, Stender S, Anderson HO, Hansen BF, Nordestgaard BG. Antiatherogenic effect of estrogen abolished by balloon catheter injury in cholesterol-clamped rabbits. Arterioscler Thromb Vasc Biol. 1997;17:1504-1511.
52. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation. 1990;81:1680-1687.
53. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest. 1992;90:1168-1172.
54. Wang B, Singer AH, Tsao P, Drexler H, Kosek J, Cooke JP. Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit. J Am Coll Cardiol. 1994;3:452-458.
55. Cayette AJ, Palacino JJ, Horten K, Cohen RA. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb. 1994;14: 746-752.
56. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest. 1993;91: 2546-2551.
57. Sholley MM, Guddas SA, Schwartz CC, Kalimi M. Dehydroepiandrosterone and related steroids induce multilamellar lipid structures in cultured human endothelial cells. Am J Pathol. 1990;136:1187-1199.
58. Rao MS, Ide RE, Subbarao V, Reddy AJ. Dehydroepiandrosterone induced peroxisome proliferation in the rat: evaluation of sex differences. Proc Soc Exp Biol Med. 1994;20:186-190.
59. Blauer KL, Poth M, Rogers WM, Bernton EW. Dehydroepiandrosterone antagonizes the suppressive effects of dexamethasone on lymphocyte proliferation. Endocrinology. 1991;129:3174-3179.
60. Esaki T, Hayashi T, Muto E, Yamada K, Kuzuya M, Iguchi A. Expression of inducible nitric oxide synthase in T lymphocytes and macrophages of cholesterol-fed rabbits. Atherosclerosis. 1997;128:39-46.